Listed

SAB Biotherapeutics, Inc.

SABSNasdaqCIK 1833214HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$114.7k, Q4 FY2024
Operating income−$23.4m, Q2 FY2026
Net income−$22.5m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m1.3Revenue, Q3 FY2023, three months to 2023-09-30$1.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-06, accession 0000950170-24-122443.Report this figure0.3Revenue, Q4 FY2023, three months to 2023-12-31$305.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-31, accession 0000950170-25-046994. Derived: 12-month figure less the 9-month figure.Report this figure0.9Revenue, Q1 FY2024, three months to 2024-03-31$944.6k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-09, accession 0000950170-25-067554.Report this figure0.3Revenue, Q2 FY2024, three months to 2024-06-30$263.1k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0000950170-25-104566.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001193125-25-280572. Derived: 9-month figure less the 6-month figure.Report this figure0.1Revenue, Q4 FY2024, three months to 2024-12-31$114.7k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-09, accession 0001833214-26-000003. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m4.0Research and development, Q3 FY2023, three months to 2023-09-30$4.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0000950170-24-122443.Report this figure4.3Research and development, Q4 FY2023, three months to 2023-12-31$4.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0000950170-25-046994. Derived: 12-month figure less the 9-month figure.Report this figure8.1Research and development, Q1 FY2024, three months to 2024-03-31$8.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-09, accession 0000950170-25-067554.Report this figure6.8Research and development, Q2 FY2024, three months to 2024-06-30$6.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-104566.Report this figure7.8Research and development, Q3 FY2024, three months to 2024-09-30$7.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure7.7Research and development, Q4 FY2024, three months to 2024-12-31$7.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001833214-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure7.7Research and development, Q1 FY2025, three months to 2025-03-31$7.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure7.0Research and development, Q2 FY2025, three months to 2025-06-30$7.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure9.0Research and development, Q3 FY2025, three months to 2025-09-30$9.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure10.7Research and development, Q4 FY2025, three months to 2025-12-31$10.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001833214-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure13.4Research and development, Q1 FY2026, three months to 2026-03-31$13.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure16.2Research and development, Q2 FY2026, three months to 2026-06-30$16.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure
Operating income$m(5.3)Operating income, Q3 FY2023, three months to 2023-09-30−$5.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122443.Report this figure(18.9)Operating income, Q4 FY2023, three months to 2023-12-31−$18.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-046994. Derived: 12-month figure less the 9-month figure.Report this figure(11.4)Operating income, Q1 FY2024, three months to 2024-03-31−$11.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-09, accession 0000950170-25-067554.Report this figure(10.2)Operating income, Q2 FY2024, three months to 2024-06-30−$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-104566.Report this figure(11.3)Operating income, Q3 FY2024, three months to 2024-09-30−$11.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure(10.0)Operating income, Q4 FY2024, three months to 2024-12-31−$10.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001833214-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure(10.8)Operating income, Q1 FY2025, three months to 2025-03-31−$10.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure(9.7)Operating income, Q2 FY2025, three months to 2025-06-30−$9.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure(12.7)Operating income, Q3 FY2025, three months to 2025-09-30−$12.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure(15.8)Operating income, Q4 FY2025, three months to 2025-12-31−$15.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001833214-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure(20.0)Operating income, Q1 FY2026, three months to 2026-03-31−$20.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure(23.4)Operating income, Q2 FY2026, three months to 2026-06-30−$23.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure
Interest expense$m0.1Interest expense, Q3 FY2023, three months to 2023-09-30$69.7k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-13, accession 0000950170-23-063076.Report this figure0.1Interest expense, Q4 FY2023, three months to 2023-12-31$77.9k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-29, accession 0000950170-24-038219. Derived: 12-month figure less the 9-month figure.Report this figure0.1Interest expense, Q1 FY2024, three months to 2024-03-31$76.4k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-20, accession 0000950170-24-062367.Report this figure0.1Interest expense, Q2 FY2024, three months to 2024-06-30$93.1k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-08, accession 0000950170-24-094084.Report this figure0.1Interest expense, Q3 FY2024, three months to 2024-09-30$78.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure0.1Interest expense, Q4 FY2024, three months to 2024-12-31$70.9k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-09, accession 0001833214-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure0.1Interest expense, Q1 FY2025, three months to 2025-03-31$69.6k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure0.1Interest expense, Q2 FY2025, three months to 2025-06-30$64.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$43.3k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure0.1Interest expense, Q4 FY2025, three months to 2025-12-31$63.5k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-09, accession 0001833214-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure0.1Interest expense, Q1 FY2026, three months to 2026-03-31$62.7k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure0.1Interest expense, Q2 FY2026, three months to 2026-06-30$62.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(5.1)Net income, Q3 FY2023, three months to 2023-09-30−$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122443.Report this figure(22.9)Net income, Q4 FY2023, three months to 2023-12-31−$22.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-046994. Derived: 12-month figure less the 9-month figure.Report this figure(5.0)Net income, Q1 FY2024, three months to 2024-03-31−$5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure(7.3)Net income, Q2 FY2024, three months to 2024-06-30−$7.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure(10.3)Net income, Q3 FY2024, three months to 2024-09-30−$10.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure(11.4)Net income, Q4 FY2024, three months to 2024-12-31−$11.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001833214-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure(5.2)Net income, Q1 FY2025, three months to 2025-03-31−$5.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure(10.1)Net income, Q2 FY2025, three months to 2025-06-30−$10.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure45.4Net income, Q3 FY2025, three months to 2025-09-30$45.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure(16.9)Net income, Q4 FY2025, three months to 2025-12-31−$16.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001833214-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure(18.9)Net income, Q1 FY2026, three months to 2026-03-31−$18.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure(22.5)Net income, Q2 FY2026, three months to 2026-06-30−$22.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure
Diluted EPS$ per share(0.97)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.97 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0000950170-24-122443.Report this figurenot reported(0.54)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-09, accession 0000950170-25-067554.Report this figure(0.79)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.79 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-104566.Report this figure(1.12)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figurenot reported(0.56)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure(1.09)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure(0.21)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figurenot reported(0.35)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure(0.28)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure
Basic EPS$ per share(0.97)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.97 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0000950170-24-122443.Report this figurenot reported(0.54)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-09, accession 0000950170-25-067554.Report this figure(0.79)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.79 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-104566.Report this figure(1.12)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figurenot reported(0.56)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.56 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure(1.09)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure0.50Basic EPS, Q3 FY2025, three months to 2025-09-30$0.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figurenot reported(0.35)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure(0.28)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure

Balance sheet

Cash and equivalents$8.3m, Q2 FY2026
Shareholders' equity$214.8m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m2.4Cash and equivalents, Q3 FY2023, at 2023-09-30$2.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0000950170-23-063076.Report this figure56.6Cash and equivalents, FY2023, at 2023-12-31$56.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0000950170-25-046994.Report this figure14.0Cash and equivalents, Q1 FY2024, at 2024-03-31$14.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-20, accession 0000950170-24-062367.Report this figure17.2Cash and equivalents, Q2 FY2024, at 2024-06-30$17.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000950170-24-094084.Report this figure9.2Cash and equivalents, Q3 FY2024, at 2024-09-30$9.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0000950170-24-122443.Report this figure8.9Cash and equivalents, FY2024, at 2024-12-31$8.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-09, accession 0001833214-26-000003.Report this figure5.6Cash and equivalents, Q1 FY2025, at 2025-03-31$5.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-09, accession 0000950170-25-067554.Report this figure3.7Cash and equivalents, Q2 FY2025, at 2025-06-30$3.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-104566.Report this figure29.4Cash and equivalents, Q3 FY2025, at 2025-09-30$29.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure10.5Cash and equivalents, FY2025, at 2025-12-31$10.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure20.5Cash and equivalents, Q1 FY2026, at 2026-03-31$20.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure8.3Cash and equivalents, Q2 FY2026, at 2026-06-30$8.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure
Current assets$m3.1Current assets, Q3 FY2023, at 2023-09-30$3.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0000950170-23-063076.Report this figure58.9Current assets, FY2023, at 2023-12-31$58.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0000950170-25-046994.Report this figure47.0Current assets, Q1 FY2024, at 2024-03-31$47.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-20, accession 0000950170-24-062367.Report this figure39.6Current assets, Q2 FY2024, at 2024-06-30$39.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094084.Report this figure32.5Current assets, Q3 FY2024, at 2024-09-30$32.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122443.Report this figure23.8Current assets, FY2024, at 2024-12-31$23.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-09, accession 0001833214-26-000003.Report this figure16.3Current assets, Q1 FY2025, at 2025-03-31$16.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-09, accession 0000950170-25-067554.Report this figure9.3Current assets, Q2 FY2025, at 2025-06-30$9.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104566.Report this figure113Current assets, Q3 FY2025, at 2025-09-30$113.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure101Current assets, FY2025, at 2025-12-31$101.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure113Current assets, Q1 FY2026, at 2026-03-31$112.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure108Current assets, Q2 FY2026, at 2026-06-30$107.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure
Total assets$m28.3Total assets, Q3 FY2023, at 2023-09-30$28.3m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0000950170-23-063076.Report this figure83.9Total assets, FY2023, at 2023-12-31$83.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0000950170-25-046994.Report this figure71.4Total assets, Q1 FY2024, at 2024-03-31$71.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-20, accession 0000950170-24-062367.Report this figure61.9Total assets, Q2 FY2024, at 2024-06-30$61.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-094084.Report this figure53.8Total assets, Q3 FY2024, at 2024-09-30$53.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0000950170-24-122443.Report this figure44.2Total assets, FY2024, at 2024-12-31$44.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-09, accession 0001833214-26-000003.Report this figure38.1Total assets, Q1 FY2025, at 2025-03-31$38.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-09, accession 0000950170-25-067554.Report this figure30.1Total assets, Q2 FY2025, at 2025-06-30$30.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-104566.Report this figure183Total assets, Q3 FY2025, at 2025-09-30$183.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure173Total assets, FY2025, at 2025-12-31$172.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure248Total assets, Q1 FY2026, at 2026-03-31$248.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure238Total assets, Q2 FY2026, at 2026-06-30$238.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure
Current liabilities$m9.2Current liabilities, Q3 FY2023, at 2023-09-30$9.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0000950170-23-063076.Report this figure10.8Current liabilities, FY2023, at 2023-12-31$10.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0000950170-25-046994.Report this figure8.3Current liabilities, Q1 FY2024, at 2024-03-31$8.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-20, accession 0000950170-24-062367.Report this figure7.6Current liabilities, Q2 FY2024, at 2024-06-30$7.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094084.Report this figure8.8Current liabilities, Q3 FY2024, at 2024-09-30$8.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122443.Report this figure8.0Current liabilities, FY2024, at 2024-12-31$8.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-09, accession 0001833214-26-000003.Report this figure9.7Current liabilities, Q1 FY2025, at 2025-03-31$9.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-09, accession 0000950170-25-067554.Report this figure10.7Current liabilities, Q2 FY2025, at 2025-06-30$10.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104566.Report this figure10.8Current liabilities, Q3 FY2025, at 2025-09-30$10.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure10.7Current liabilities, FY2025, at 2025-12-31$10.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure9.9Current liabilities, Q1 FY2026, at 2026-03-31$9.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure11.7Current liabilities, Q2 FY2026, at 2026-06-30$11.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure
Total liabilities$m13.1Total liabilities, Q3 FY2023, at 2023-09-30$13.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0000950170-23-063076.Report this figure26.6Total liabilities, FY2023, at 2023-12-31$26.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0000950170-25-046994.Report this figure18.5Total liabilities, Q1 FY2024, at 2024-03-31$18.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-20, accession 0000950170-24-062367.Report this figure15.8Total liabilities, Q2 FY2024, at 2024-06-30$15.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-094084.Report this figure16.9Total liabilities, Q3 FY2024, at 2024-09-30$16.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0000950170-24-122443.Report this figure18.2Total liabilities, FY2024, at 2024-12-31$18.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-09, accession 0001833214-26-000003.Report this figure16.7Total liabilities, Q1 FY2025, at 2025-03-31$16.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-09, accession 0000950170-25-067554.Report this figure18.1Total liabilities, Q2 FY2025, at 2025-06-30$18.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-104566.Report this figure18.4Total liabilities, Q3 FY2025, at 2025-09-30$18.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure21.3Total liabilities, FY2025, at 2025-12-31$21.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure21.2Total liabilities, Q1 FY2026, at 2026-03-31$21.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure23.4Total liabilities, Q2 FY2026, at 2026-06-30$23.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure
Shareholders' equity$m15.3Shareholders' equity, Q3 FY2023, at 2023-09-30$15.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0000950170-24-122443.Report this figure57.3Shareholders' equity, FY2023, at 2023-12-31$57.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-09, accession 0001833214-26-000003.Report this figure52.8Shareholders' equity, Q1 FY2024, at 2024-03-31$52.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure46.1Shareholders' equity, Q2 FY2024, at 2024-06-30$46.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure36.9Shareholders' equity, Q3 FY2024, at 2024-09-30$36.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure26.0Shareholders' equity, FY2024, at 2024-12-31$26.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure21.4Shareholders' equity, Q1 FY2025, at 2025-03-31$21.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure12.0Shareholders' equity, Q2 FY2025, at 2025-06-30$12.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure165Shareholders' equity, Q3 FY2025, at 2025-09-30$165.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure151Shareholders' equity, FY2025, at 2025-12-31$151.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure227Shareholders' equity, Q1 FY2026, at 2026-03-31$227.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure215Shareholders' equity, Q2 FY2026, at 2026-06-30$214.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure

Cash flow

Operating cash flow−$9.8m, Q2 FY2026
Capital expenditure$1.6m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(5.2)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$5.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0000950170-24-122443. Derived: 9-month figure less the 6-month figure.Report this figure(13.4)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$13.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0000950170-25-046994. Derived: 12-month figure less the 9-month figure.Report this figure(10.8)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$10.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-09, accession 0000950170-25-067554.Report this figure(7.7)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$7.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-104566. Derived: 6-month figure less the 3-month figure.Report this figure(6.3)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$6.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001193125-25-280572. Derived: 9-month figure less the 6-month figure.Report this figure(9.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$9.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001833214-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure(7.8)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$7.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure(7.2)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-336783. Derived: 6-month figure less the 3-month figure.Report this figure(13.0)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$13.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001193125-25-280572. Derived: 9-month figure less the 6-month figure.Report this figure(16.8)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$16.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001833214-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure(14.3)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$14.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure(9.8)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$9.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-336783. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, Q3 FY2023, three months to 2023-09-30$85.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0000950170-24-122443. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$67.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0000950170-25-046994. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$129.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-09, accession 0000950170-25-067554.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$52.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-104566. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$100.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001193125-25-280572. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$55.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-09, accession 0001833214-26-000003. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reported1.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$983.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure1.6Capital expenditure, Q2 FY2026, three months to 2026-06-30$1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-336783. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)79.75m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares43.0Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3043,030,885 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0000950170-23-063076.Report this figure5.0Diluted shares (weighted), Q1 FY2023, three months to 2023-03-315,039,705 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-20, accession 0000950170-24-062367.Report this figure5.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-305,042,126 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-094084.Report this figure5.2Diluted shares (weighted), Q3 FY2023, three months to 2023-09-305,240,600 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0000950170-24-122443.Report this figure9.2Diluted shares (weighted), Q1 FY2024, three months to 2024-03-319,241,940 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-09, accession 0000950170-25-067554.Report this figure9.3Diluted shares (weighted), Q2 FY2024, three months to 2024-06-309,255,025 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-104566.Report this figure9.3Diluted shares (weighted), Q3 FY2024, three months to 2024-09-309,259,192 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure9.3Diluted shares (weighted), Q1 FY2025, three months to 2025-03-319,291,641 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure9.3Diluted shares (weighted), Q2 FY2025, three months to 2025-06-309,294,469 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure77.9Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3077,863,263 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001193125-25-280572.Report this figure53.6Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3153,558,639 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-218195.Report this figure79.8Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3079,753,100 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure

Shares outstanding: 90.99mShares outstanding, period not labelled, at 2026-08-0390,986,368 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336783.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.